Next Article in Journal
Nutritional Characterization and Phenolic Profiling of Moringa oleifera Leaves Grown in Chad, Sahrawi Refugee Camps, and Haiti
Next Article in Special Issue
Two Effective Routes for Removing Lineage Restriction Roadblocks: From Somatic Cells to Hepatocytes
Previous Article in Journal
Detecting Antigen-Specific T Cell Responses: From Bulk Populations to Single Cells
Previous Article in Special Issue
Potential Effect of CD271 on Human Mesenchymal Stromal Cell Proliferation and Differentiation
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(8), 18894-18922;

Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells

Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan
Department of Cardiology, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo 160-8582, Japan
Author to whom correspondence should be addressed.
Academic Editor: Wenbin Deng
Received: 29 June 2015 / Revised: 1 August 2015 / Accepted: 3 August 2015 / Published: 12 August 2015
Full-Text   |   PDF [1150 KB, uploaded 12 August 2015]   |  


The generation of induced pluripotent stem cells (iPSCs) has opened up a new scientific frontier in medicine. This technology has made it possible to obtain pluripotent stem cells from individuals with genetic disorders. Because iPSCs carry the identical genetic anomalies related to those disorders, iPSCs are an ideal platform for medical research. The pathophysiological cellular phenotypes of genetically heritable heart diseases such as arrhythmias and cardiomyopathies, have been modeled on cell culture dishes using disease-specific iPSC-derived cardiomyocytes. These model systems can potentially provide new insights into disease mechanisms and drug discoveries. This review focuses on recent progress in cardiovascular disease modeling using iPSCs, and discusses problems and future perspectives concerning their use. View Full-Text
Keywords: iPSCs; disease modeling; cardiovascular disease iPSCs; disease modeling; cardiovascular disease

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Tanaka, A.; Yuasa, S.; Node, K.; Fukuda, K. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells. Int. J. Mol. Sci. 2015, 16, 18894-18922.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top